Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to

Nami Sugiyama1, Markku Varjosalo, Pipsa Meller

  • 1Molecular Cancer Biology Research Program, Departments of Pathology and Virology, Haartman Institute, Helsinki, Finland.

Cancer Research
|September 30, 2010
PubMed

Insights

The FGFR4-R388 gene variant promotes cancer progression by increasing matrix degradation and invasion, while the FGFR4-G388 allele has the opposite effect. This explains the link between FGFR4-R388 and poor cancer prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Aberrant fibroblast growth factor receptor 4 (FGFR4) expression and genetic variations are implicated in tumor progression and resistance to cancer therapies.
  • The FGFR4-R388 risk variant is associated with poor cancer prognosis.
  • Membrane-type 1 matrix metalloproteinase (MT1-MMP) plays a role in extracellular matrix degradation and tumor invasion.

Purpose of the Study:

  • To elucidate a novel mechanism of tumor progression involving matrix degradation and epithelial-to-mesenchymal transition.
  • To investigate the role of the FGFR4-R388 variant in MT1-MMP induction and tumor cell invasion.
  • To explore the impact of FGFR4 variants on cancer cell behavior and prognosis.

Main Methods:

  • Analysis of FGFR4 and MT1-MMP expression in human cancer biopsies (breast, prostate).
  • In vitro studies using cultured prostate carcinoma cell lines with FGFR4-R388 and FGFR4-G388 variants.
  • RNA interference (RNAi) to knockdown FGFR4-R388, FGFR4-G388, or MT1-MMP.
  • Assessment of tumor cell invasion, growth, and molecular signaling pathways (FGFR substrate 2, Src, cadherins).
  • In vivo studies to evaluate tumor growth and MT1-MMP content after gene silencing.

Main Results:

  • FGFR4 and MT1-MMP were upregulated and coexpressed at invasive fronts in various human cancers, notably prostate carcinoma.
  • The FGFR4-R388 variant enhanced MT1-MMP-dependent collagen invasion and tumor growth.
  • Knockdown of FGFR4-R388 or MT1-MMP inhibited tumor cell invasion and growth, with associated molecular changes (e.g., E-cadherin upregulation).
  • Conversely, knockdown of the FGFR4-G388 allele increased MT1-MMP and invasive tumor cell growth.

Conclusions:

  • The FGFR4-R388 variant drives tumor progression through MT1-MMP induction and matrix degradation, contributing to poor prognosis.
  • FGFR4-R388 and MT1-MMP are key players in cancer cell invasion and growth.
  • Understanding the differential roles of FGFR4 alleles (R388 vs. G388) provides insights into cancer progression mechanisms and potential therapeutic targets.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...